Relay Therapeutics, Inc. (RLAY)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
RLAY price, last 12 months
Key stats
- Previous close
- $16.51
- Open
- $16.60
- Day range
- $15.89 – $16.73
- 52-week range
- $6.28 – $21.27
- Volume
- 1.9M
- Avg volume (20 days)
- 2.6M
- Market cap
- $4.0B
Performance
Technicals and fundamentals
About Relay Therapeutics, Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $4.0B